Last reviewed · How we verify
NCT04639661
Predictors of Periodontal Outcomes Post-sanative Therapy
trial in Periodontal Diseases in 12 participants. Terminated before completion.
20 October 2021
Quick facts
| Lead sponsor | Brock University |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 12 |
| Start date | 25 November 2020 |
| Primary completion | 20 October 2021 |
| Estimated completion | 20 October 2021 |
| Sites | 2 locations across Canada |
Conditions studied
- Periodontal Diseases — all drugs for Periodontal Diseases →
- Periodontal Pocket — all drugs for Periodontal Pocket →
Sponsor
Brock University
Who can join
19 and older, any sex, with Periodontal Diseases or Periodontal Pocket. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Periodontal disease is a chronic inflammatory disease of the tissues surrounding the teeth and is one of the leading causes of tooth loss. Sanative therapy (ST) is a non-surgical procedure that allows for removal of bacteria from the deep pockets that form around teeth and is the frontline treatment for periodontal disease. Post-ST, patients require ongoing maintenance appointments to maintain their oral health, though whether risk factors for periodontal disease remain a predictor of periodontal health post-ST has not been comprehensively investigated. Risk factors to be examined include physical activity, exercise, sedentary time, flavonoid intake, protein intake, BMI, sex, age, smoking status, and number of sites with periodontal probing depth (PPD) ≥ 4mm at baseline.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04639661
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Periodontal Diseases
Currently open trials in the same condition.
- NCT07358104 — Efficacy of Camel Whey Protein and Camel Whey Protein Nanoparticles for Treating Intra-bony Periodontal Defects · NA · active not recruiting
- NCT07312045 — HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical T · recruiting
- NCT07384221 — Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients · recruiting
- NCT07530978 — ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE · recruiting
- NCT06848790 — Interdental Hygiene Methods in Young Adults · NA · recruiting
Other Brock University trials
Trials by the same sponsor.
- NCT04345250 — Bone Response to Exercise and Energy Restriction in Young Adults · NA · suspended
- NCT06530394 — Effects of Increased Greek Yogurt Consumption in Senior Adults · NA · completed
- NCT04670133 — Inulin Supplementation During Sanative Therapy to Further Improve Periodontal Healing · NA · withdrawn
- NCT04380155 — Cycling Duration and Bone Markers in in Active Young Adults · NA · withdrawn
- NCT05922462 — Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04639661 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brock University
- Last refreshed: 23 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04639661.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing